Arrhythmias & electrophysiology

Zero-contrast left atrial appendage closure, a feasible alternative for patients with a high risk of contrast-induced nephropathy: Systematic literature review and meta-analysis

Heart RhythmPublished Systematic review and meta-analysis

Pooled result · Feasibility: successful implantation, recaptures, fluoroscopy timeResult — go to the resultMean difference −4.03 CI −7.72 to −0.34

Authors' conclusion

Zero-contrast LAAC is a feasible alternative. The success and complication rates are consistent with those of conventional LAAC. Aside from the inherent benefit of zero-contrast exposure, this technique allows a reduction in fluoroscopy time.

Study context

Population
Patients with nonvalvular AF undergoing left atrial appendage closure
Participants
367 patients5 studies
Comparison
Zero-contrast left atrial appendage closure (LAAC) vs conventional LAAC
Outcome
Feasibility and safety of zero-contrast LAAC
Methodological detailsrandom-effects model
  • Random-effects model

Pooled result

As reported in the abstract

Feasibility: successful implantation, recaptures, fluoroscopy time

Mean difference

−4.03

CI −7.72 to −0.34

P = 0.03

By group

Zero-contrast

100%

Zero-contrastvs Conventional
mean difference −4.03 (CI −7.72 to −0.34); P = 0.03
Mean number of recaptures: no significant difference between groups (MD −0.15; CI −0.67 to 0.37; I2 = 0%)
P = 0.58

Safety

Procedure-related complications, peridevice leak, device-associated thrombus

Not significantly different between groups

Original publication

Zero-contrast left atrial appendage closure, a feasible alternative for patients with a high risk of contrast-induced nephropathy: Systematic literature review and meta-analysis. Heart Rhythm. Published 13 May 2024. doi:10.1016/j.hrthm.2024.05.016

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.